| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 567.8 | 566.9 |
| Gross profit | 368.8 | 292.0 |
| Profit before tax | 83.1 | -92.4 |
| Net income | 927.4 | -408.9 |
| EPS (diluted, $ a share) | $22.28 | $-9.24 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +0.1% |
|---|---|
| Gross margin | 65.0% |
| Operating margin | 18.6% |
10-Q filed with the SEC, NYSE: TFX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Teleflex Inc: key numbers
- Share price
- $157.10Close, Nov 16
- Market cap
- $6.23B
- Shares outstanding
- 39.66MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Teleflex Inc
All →Teleflex Financial Results
Teleflex reported Q3 2026 revenue of $567.8 million, representing 3.0% pro forma adjusted constant currency growth. The company raised its full-year 2026 adjusted EPS guidance to a range of $7.50 to $7.75 and completed $350 million in share repurchases since July 1, 2026.
- Term
- Q3 2026
“We are pleased with our third quarter performance, which included margin expansion and robust earnings per share growth, even when excluding IEEPA tariff refunds.”
Jason Weidman, Teleflex’s President and Chief Executive Officer
“Our priorities are clear: strengthening our foundation by delivering our transformation, inclusive of the completion of our Strategic Divestitures and the Vascular Intervention integration, accelerating our organizational effectiveness, and elevating our growth profile within a balanced capital allocation framework.”
Jason Weidman, Teleflex’s President and Chief Executive Officer